Dow Up 1.11% Nasdaq Up 2.08%

Celsion Corp. (CLSN)

-NasdaqCM
2.62 Up 0.02(0.77%) 2:14PM EDT - Nasdaq Real Time Price
Prev Close:2.60
Open:2.63
Bid:2.61 x 2000
Ask:2.63 x 1000
1y Target Est:8.00
Beta:1.85
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:2.60 - 2.64
52wk Range:2.38 - 5.90
Volume:9,214
Avg Vol (3m):102,912
Market Cap:52.29M
P/E (ttm):N/A
EPS (ttm):-1.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLSN

Comparison

Symbol% ChgMkt Cap
CLSNUp 0.77%52.29M
BSDMUp 2.30%17.86M
DCTHDown 1.14%16.44M
MMSIUp 0.56%548.13M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):103.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.33
Quarterly EPS Est (Sep-14) :-0.32
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback